Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
PKC-θ selectively controls the adhesion-stimulating molecule Rap1
2008
Cancer statistics, 2022
2022 Standout
Is Transport Infrastructure Effective?: Transport Infrastructure and Accessibility: Impacts on the Space Economy
1998
Cancer statistics, 2023
2023 Standout
TLR Ligands Act Directly upon T Cells to Restore Proliferation in the Absence of Protein Kinase C-θ Signaling and Promote Autoimmune Myocarditis
2007
Kaempferol and inflammation: From chemistry to medicine
2015
Current and emerging systemic therapies for cutaneous metastatic melanoma
2019
Melanoma
2018
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes
2011
S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling
2012
Vascular Actions of Estrogens: Functional Implications
2008
Mechanisms of Thrombus Formation
2008 Standout
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Contribution of platelets to tumour metastasis
2011 Standout
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
2011
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies
2018
Shared Principles in NF-κB Signaling
2008 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
The complex transcriptional landscape of the anucleate human platelet
2013
Macrophages in immunoregulation and therapeutics
2023 Standout
HPK1 competes with ADAP for SLP‐76 binding and via Rap1 negatively affects T‐cell adhesion
2010 StandoutNobel
Commitment to the Regulatory T Cell Lineage Requires CARMA1 in the Thymus but Not in the Periphery
2009 StandoutNobel
Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease
2018
Antigen-Receptor Signaling to Nuclear Factor κB
2006
Novel adjuvant options for cutaneous melanoma
2021
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
THP-1 cell line: An in vitro cell model for immune modulation approach
2014 Standout
A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
2010 Standout
Colorectal cancer
2019 Standout
Immune checkpoint inhibitors in melanoma
2021
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Synthetic lethality as an engine for cancer drug target discovery
2019
Platelet Activation and Atherothrombosis
2007 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
The development of allergic inflammation
2008 StandoutNature
Platelets and the immune continuum
2011 Standout
Protein kinase C theta (PKCθ): A key player in T cell life and death
2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial
2007
Atherosclerosis
2007
Mast-cell responses to pathogens
2004
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
2013
Next Generation Sequencing Analysis of Human Platelet PolyA+ mRNAs and rRNA-Depleted Total RNA
2013 StandoutNobel
Inflammation in Atherosclerosis
2009 Standout
Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications
2015
Understanding Gastroenterologist Adherence to Polyp Surveillance Guidelines
2012
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Mast cells in the development of adaptive immune responses
2005 Standout
Integrated signalling pathways for mast-cell activation
2006 Standout
DNA Methylation in Inflammatory Genes among Children with Obstructive Sleep Apnea
2011
Epigenetic changes by DNA methylation in chronic and intermittent hypoxia
2017 StandoutNobel
Nouvelle Cuisine: Platelets Served with Inflammation
2015
Protective Role of 14-Deoxy-11,12-didehydroandrographolide, a Noncytotoxic Analogue of Andrographolide, in Allergic Airway Inflammation
2011 Standout
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
2019
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
2009
Accessibility evaluation of land-use and transport strategies: review and research directions
2003 Standout
mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets
2006
Th9 cells: differentiation and disease
2013
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
The mastocyte: the “other” inflammatory cell in immunopathogenesis
2004
Inflammation in Atherosclerosis: Transition From Theory to Practice
2010
Quality indicators for colonoscopy
2014 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Enhanced Expression of the S100A8/A9 Complex in Acute Myocardial Infarction Patients
2010
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
2007
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
2006
Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit
2014
T Cell Activation
2009 Standout
Platelets and platelet-like particles mediate intercellular RNA transfer
2012
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Michael D. Pickard being referenced
Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2014
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
2018
FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines
2003
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
2018
Follow up of patients with colorectal polyps: are the BSG guidelines being adhered to?
2007
PKC-θ-Deficient Mice Are Protected from Th1-Dependent Antigen-Induced Arthritis
2006
Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events
2006
Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma.
2018
Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma
2017